Connect with us

Tools & Platforms

How spy agencies are experimenting with the newest AI models

Published

on


ON THE SAME day as Donald Trump’s inauguration as president DeepSeek, a Chinese company, released a world-class large language model (LLM). It was a wake-up call, observed Mr Trump. Mark Warner, vice-chair of the Senate Intelligence Committee, says that America’s intelligence community (IC), a group of 18 agencies and organisations, was “caught off guard”.



Source link

Tools & Platforms

AI-Enabled Heart Diagnostics Put HeartFlow (HTFL) in the Spotlight

Published

on


HeartFlow, Inc. (NASDAQ:HTFL) is one of the AI Stocks to Watch Out For in 2025On September 2, JPMorgan analyst Robbie Marcus initiates coverage on the stock with an Overweight rating and a price target of $36.00.

The firm believes that Heartflow is “one of the clearest and most pioneering downstream beneficiaries of the AI revolution in the healthcare sector.”

The company is using artificial intelligence in healthcare to help diagnose heart disease. Through their technology, doctors can gain better insights of a patient’s heart while reducing costs and improving workflow.

Jirsak/Shutterstock.com

JP Morgan believes that even though investors are rightly focused on the hardware, data, and infrastructure that’s driving modern artificial intelligence, HTFL stands out as a clear and pioneering downstream beneficiary of the AI revolution in healthcare.

“The company operates at the unique intersection of regulated healthcare and technology through its novel, AI-enabled, diagnostic software for coronary artery disease (CAD). The novel platform uses AI and advanced computational fluid dynamics to create a personalized 3D model of a patient’s heart based off of a single coronary computed tomography angiography (CCTA). Heartflow is one of the first MedTech companies to offer a clinically meaningful and reimbursed product that leverages modern day computing power and machine learning/AI to address a clinical unmet need in coronary artery disease (CAD), while simultaneously offering the potential to streamline procedural workflow and lower overall cost of care. As one of the few pure-play software MedTech businesses, Heartflow benefits from a capital-light business model, an excellent gross margin profile, clinical/regulatory moat with healthy reimbursement, and a highly differentiated diagnostic solution in a large, untapped market.”

HeartFlow, Inc. (NASDAQ:HTFL) is a medical technology company.

While we acknowledge the potential of HTFL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Must-Watch AI Stocks on Wall Street and 10 AI Stocks Investors Are Watching Closely.

Disclosure: None.



Source link

Continue Reading

Tools & Platforms

Where's the Fun in AI Gambling? – WIRED

Published

on



Where’s the Fun in AI Gambling?  WIRED



Source link

Continue Reading

Tools & Platforms

Tesla Shareholders to Vote on Potential Investment in Musk’s AI Startup xAI

Published

on


Tesla shareholders will soon decide whether the company should invest in Elon Musk’s artificial intelligence company, xAI. According to Tesla’s annual proxy statement, a shareholder proposal will put the question to a vote at the November 6 meeting . Bloomberg reports that xAI merged with Musk’s social media company, X, earlier this year, and that SpaceX committed $2 billion as part of a $5 billion equity fundraising round. This funding underscores the existing financial ties among Musk’s enterprises.

This vote occurs amid mounting pressure on Tesla as vehicle sales weaken and its Robotaxi rollout progresses slowly. The board has taken a neutral stance on the proposal, foregoing its usual recommendation to support or oppose shareholder-led items. The outcome may influence whether Tesla deepens its involvement in AI and robotics through alignment with xAI’s technology and strategy.

Tesla shareholders will cast votes at the November 6 annual meeting on whether to authorize the company to invest in Elon Musk’s artificial intelligence startup, xAI. The investment proposal originates from a shareholder submission, which the company will include in its proxy materials after receiving multiple proper requests. (Tesla will include one properly submitted proposal on each topic in its proxy statement). Tesla’s board has taken a neutral stance, declining to recommend either for or against the proposal.

Broader Context:

Questions about Elon Musk’s expanding influence over Tesla have drawn renewed scrutiny amid the xAI investment proposal. Corporate governance experts cite potential conflicts of interest arising from Musk’s dual role as Tesla CEO and xAI founder. Some investors have expressed concerns that resources and talent may be diverted from Tesla to xAI, risking dilution of focus at the automaker.

Shareholder pressure has intensified amid Tesla’s recent performance challenges. The company faces a notable drop in vehicle deliveries and delays in its robotaxi programme, highlighting the urgency of strategic clarity. At the same time, Musk’s proposed compensation package, potentially worth up to US $1 trillion, would significantly increase his influence over Tesla’s direction. Critics argue the scale raises serious governance risks.

In this light, the vote on investing in xAI becomes a measure of how shareholders view Musk’s multifaceted role and the balance between strategic ambition and fiduciary responsibility.

What to Watch Ahead of the Vote

Investors will observe whether the proposal gains sufficient support when Tesla shareholders cast their votes on November 6. Close attention will fall on shareholder sentiment regarding potential conflicts of interest, given Elon Musk’s leadership roles at both Tesla and xAI. Analysts will also monitor media and investor reactions leading up to the vote to assess whether the proposal is seen as a strategic opportunity or a governance risk. The result may signal how shareholders balance innovation aspirations with oversight concerns.

Final Take

The upcoming vote on investing in xAI serves as a critical crossroads for Tesla’s identity and governance. On one hand, closer alignment with xAI may support Tesla’s push into AI and robotics. On the other hand, the move raises concerns about shareholder oversight. Elon Musk’s influence across multiple companies, including his history of reallocating resources, such as GPUs, from Tesla to xAI, illustrates the blurred boundaries within his business network 

Meanwhile, Tesla’s board has proposed a compensation package that could award Musk up to US $1 trillion in stock if ambitious targets are met, increasing his control notably. Together these developments suggest a moment of reckoning. Shareholders must balance the potential gains from AI and robotics against legitimate governance concerns at one of the world’s most closely held public companies.



Source link

Continue Reading

Trending